2026
12 August, 2026
Invitation to FluoGuide A/S live webcast on 25 August 2026
FluoGuide A/S will publish its interim report for Q2 2026 on Tuesday, 25 August 2026. Later that day, CEO Morten Albrechtsen and CFO...
1 July, 2026
Update on 2026 Outlook and Company progress
Copenhagen, Denmark, 1 July 2026 – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech...
Copenhagen, Denmark, 29 June 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company maximizing...
27 May, 2026
FluoGuide A/S publishes interim report for Q1 2026
Copenhagen, Denmark, 27 May 2026 – Fluoguide A/S (“FluoGuide” or the “Company”) today releases its results...
13 May, 2026
Invitation to brain surgery simulation
Copenhagen, Denmark, 13 May 2026 – FluoGuide A/S ("FluoGuide" or the "Company") is inviting investors to...
FluoGuide A/S will publish its interim report for Q1 2026 on Wednesday, 27 May 2026. Later that day, CEO Morten Albrechtsen and CFO...
10 April, 2026
Positive interim results from an investigator-initiated study of FG001 in meningioma and low-grade glioma surgery, re-presented at SNOG
Copenhagen, Denmark, 10 April 2026 – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech...
25 March, 2026
Minutes from Annual General Meeting in FluoGuide A/S
Copenhagen, Denmark, 25 March 2026 – FluoGuide A/S (“FluoGuide” or the “Company”) held its annual general...
Copenhagen, Denmark, 18 March 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...
